Title of article :
Incidence of metabolic syndrome and determinants of its progression in Southern Iran: A 5‑year longitudinal follow‑up study
Author/Authors :
Bakhshayeshkaram, Marzieh Shiraz Health Policy Research Center - Institute of Health - Shiraz University of Medical Sciences, Shiraz, Iran , Heydari, Taghi Department of Biostatistics - Shiraz Health Policy Research Center - Institute of Health - Shiraz University of Medical Sciences, Shiraz, Iran , Honarvar, Behnam Department of Public and Community Medicine - Shiraz Health Policy Research Center - Institute of Health - Shiraz University of Medical Sciences, Shiraz, Iran , Keshani, Parisa Department of Nutrition - Shiraz HIV/AIDS Research Center - Institute of Health - Shiraz University of Medical Sciences, Shiraz, Iran , Roozbeh, Jamshid Department of Internal Medicine, Shiraz Nephro‑Urology Research Center - Shiraz University of Medical Sciences, Shiraz, Iran , Dabbaghmanesh, Mohammad Hossein Department of Internal Medicine - Shiraz Endocrinology and Metabolism Research Center - Shiraz University of Medical Sciences, Shiraz, Iran , Bagheri Lankarani, Kamran Department of Internal Medicine - Gastroenterologist - Shiraz Health Policy Research Center - Institute of Health - Shiraz University of Medical Sciences, Shiraz, Iran
Abstract :
Background: Metabolic syndrome (MetS) is a cluster of conditions increasing the risk of serious diseases. This study aimed to
define the predictors of MetS incident in a community‑based cohort in Southern Iran, during a mean follow‑up period of 5.1 years.
Materials and Methods: During the mean follow‑up period of 5.1 years, a cohort study was conducted on 819 Iranian adults
aged ≥18 years at baseline and followed to determine the incidence and predictors of MetS progression in Shiraz, a main urban
region in the southern part of Iran. The International Diabetes Federation Guideline was used to detect the MetS. Multiple Cox’s
proportional hazards models were also used to estimate the predictors of new‑onset MetS. Results: The prevalence of MetS was
25.9% at baseline, and the overall incidence of subsequent MetS was 5.45% (95% confidence interval [CI]: 4.47–6.59). The incidence of
MetS was significantly higher in women (7.12% [95% CI: 5.52–9.05]) than in men (3.92% [95% CI: 2.80–5.34]). Moreover, it increased
by 5.02 (95% CI, 3.75–6.58) among individuals who had one metabolic component and by 12.65 (95% CI, 9.72–16.18) for those who
had three or more components (P < 0001). The incidence of MetS was also analyzed using the multiple Cox’s proportional hazards
model for potential risk factors, and it was revealed that female gender (hazard ratio [HR] 2.45; 95% CI: 1.33, 4.50; P = 0.004),
higher body mass index (HR 3.13; 95% CI: 1.43.6.84; P = 0.012), increased abdominal obesity (HR 1.45; 95% CI 0.85, 2.46; P = 0.045),
smoking (HR 4.79; 95% CI 2.09, 10.97; P < 0.001), and lower high‑density lipoprotein (HR 0.53; 95% CI: 0.29, 1.00;P = 0.044)
significantly predicted the onset of MetS at baseline; however, age, systolic and diastolic blood pressure, serum uric acid, fasting
blood glucose, cholesterol, triglyceride and creatinine, estimated glomerular filtration rate, marital status, level of education, and
level of physical activity did not independently predict the onset of MetS when other covariates were considered. Conclusion: This
study showed the high‑incidence rates of MetS in males and females residing in Southern Iran. Therefore, the prevention through
community‑based lifestyle modification should be implemented to reduce the burden of MetS and its complications.
Keywords :
risk factors , metabolic syndrome , Incidence
Journal title :
Journal of Research in Medical Sciences